🇺🇸 FDA
Patent

US 10835514

Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives

granted A61KA61K31/40A61K31/403

Quick answer

US patent 10835514 (Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives) held by THERON PHARMACEUTICALS, INC. expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THERON PHARMACEUTICALS, INC.
Grant date
Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/40, A61K31/403, A61K31/58, A61K47/26